Avadel Pharmaceuticals
AVDL
#4910
Rank
S$2.70 B
Marketcap
S$27.58
Share price
0.00%
Change (1 day)
173.03%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -S$4.93 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are S$0.24 Billion. In 2024 the company made an earning of -S$62.56 Million, an increase over its 2023 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$4.93 Million-92.12%
2024 -S$62.56 Million-69.47%
2023 -S$0.21 Billion44.27%
2022 -S$0.15 Billion19.64%
2021 -S$0.12 Billion1732.84%
2020 -S$6.48 Million-86.83%
2019 -S$49.18 Million-65.92%
2018 -S$0.15 Billion-222.16%
2017 S$0.11 B-1053.49%
2016 -S$12.39 Million-112.59%
2015 S$98.38 M-185.94%
2014 -S$0.12 Billion66.04%
2013 -S$68.95 Million582.16%
2012 -S$10.11 Million-7.6%
2011 -S$10.94 Million-2.1%
2010 -S$11.18 Million32.52%
2009 -S$8.44 Million-64.36%
2008 -S$23.66 Million-52.93%
2007 -S$50.26 Million5.66%
2006 -S$47.57 Million17.86%
2005 -S$40.36 Million-375.09%
2004 S$14.66 M-406.44%
2003 -S$4.79 Million-145.2%
2002 S$10.58 M-363.36%
2001 -S$4.03 Million-80.62%
2000 -S$20.76 Million132.68%
1999 -S$8.92 Million-50.34%
1998 -S$17.96 Million54.85%
1997 -S$11.6 Million-28.35%
1996 -S$16.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion 6,931.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.15 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA